Mesdopetam (IRL-790) is a small molecule dopamine receptor antagonist targeting dyskinesia in Parkinson’s patients. By blocking certain dopamine receptors, it aims to reduce involuntary movements (dyskinesia) that can result from long-term dopamine replacement therapy.
Discover our Products
Science-based and high-quality devices
